Montag & Associates’s Celestica CLS Stock Holding History

Montag & Associates’s Portfolio CLS Stock Details CLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4	Closed	-$986	–	998
2025 Q3	$986	Buy	+4	New	+$806	﹤0.01%	1017

Other funds holding CLS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WRCM

Whale Rock Capital Management Boston, Massachusetts $12.5B AUM 306.52% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Montag & Associates's CLS Position: Q4 2025 in Review

Montag & Associates sold out of Celestica (CLS) in Q4 2025, closing a stake of 4 shares — an estimated $986 sold.

Montag & Associates first reported a position in CLS in Q3 2025 and held it in 1 quarter. The position peaked at $986 in Q3 2025. 809 funds tracked by Wall St. Rank hold CLS as of Q4 2025.

Montag & Associates reported no remaining Celestica position as of Q4 2025 after selling out during the quarter.
Montag & Associates sold 4 Celestica shares in Q4 2025, an estimated $986.
Montag & Associates first reported a position in Celestica in Q3 2025 and held it in 1 quarter.
Montag & Associates's Celestica position peaked at $986 in Q3 2025.
809 funds tracked by Wall St. Rank held Celestica as of Q4 2025.

Based on Montag & Associates's 13F filing for Q4 2025, filed 2 Feb 2026.